Back to 
HRT FINANCIAL LP
HRT FINANCIAL LP
SCNI1 quarters
Position history for HRT FINANCIAL LP's holdings in BIONDVAX PHARMACEUTICALS LTD
Yes. HRT Financial holds 12,088 shares of SCNI (Biondvax Pharmaceuticals), worth $3,000, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$3,000
Current Shares
12,088
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of SCNI: UBS Group AG, CITADEL ADVISORS LLC